Magnesium ions are essential for the maintenance of the functional and structural integ· rity of the myocardium. Experimental magnesium deficiency induces cardiac necrosis and enhances susceptibility to cardiotoxic agents; magnesium administration is protective. Recent investigations indicate that cellular loss of magnesium may be a basic biochemical mechanism in the evolution of myocardial lesions of diverse etiology. Other studies have shown that magnesium depletion influences coronary flow, blood clotting, and atherogenesis. This paper surveys the cardiovascular role of magnesium as it relates to certain facets of ischemic heart disease.
Loss of myocardial magnesium from ischemic hearts; anoxic hearts
Laboratory models. Magnesium loss from the myocardium is one of the earliest changes found in several cardiomyopathic animal models ( 1. 2) , including production of cardiac hypoxia by coronary ligation, by asphyxia, or by hemorrhagic hypotension ( Table 1) . The time lag after induction of hypoxia influences the degree of magnesium loss from the myocardial muscle. Cummings (3) and Cummings and Clark (4) first demonstrat~d loss of myocardial Mg (by II hr after a two-stage coronary ligation). Rigo et al. (5) found less loss of myocardial Mg in hearts analyzed 6 days after coronary ligation . Jennings (6) and Jennings and Shen {7) found that 40 min after temporary ligation there was almost one-third loss of myocardial Mg. which is not seen in hearts of dogs 1 hr after permanent ligation. Hochrein and co-workers' {8) study of hearts from guinea pigs in anoxic chambers demonstrated an early drop in magnesium that was followed by a rise . Dogs with myocardial hypoxia secondary to hemorrhagic hypotension had increased losses of myocardial Mg from 135 to 180 min after the bleeding (9).
Human material. Ventricular muscle of pa· tients who died of myocardial infarcts. reported by Iseri et al. (I 0), Meister and Schumann (II), Raab ( 12, 13) and Heggtveit et al. ( 14 ) , had significantly lower magnesium content, particularly of the infarcted portion of the heart, as compared with magnesium levels in noninfarcted segments, and in hearts of patients who died of other causes (Table 2 ). In the study of Heggtveit et al. (14) , hearts obtained at autopsy within 2 hr of death were examined grossly and microscopically. Mg was assayed in samples of left ventricular muscle by atomic absorption spectrophotometry. The mean myocardial Mg content of normal hearts from sudden traumatic deaths was 85.44 mEq/kg dry weight. Acutely infarcted heart muscle showed a 42% average decrease in Mg content. whereas the noninfarcted areas of . the same hearts showed a 19% decrease. Thi~ latter diminution was comparable to that ' found in cases of sudden coronary death without detectable infarction . Skeletal muscle Mg levels did not differ significantly between the control and coronary groups. Laurendeau and DuRuisseau (IS) re- (22) who reported no such decreases did not specify when in the course of the hospitalization for infarction the blood samples had been drawn. That these differences may be due to differ· ences in time of testing after the ischemic event, as suggested by Lossnitzer (23 ), is supported by experimental findings. Nath et al. (20) reported that I hr after experimental myocardial infarction in dogs, serum Mg levels dropped markedly. Blood drawn 24 and 48 hr after the infarction had normal levels of serum Mg. Clark and associates (24) and Cummings (3) drew blood 8 to II hr after coronary ligation, at the time the ectopic rhythm was established (and when magnesium was leaving the heart) and found elevated plasma Mg. The elevations in serum Mg after repeated bleeding of rats, withdrawing up to 40% of total blood as reported by Goldsmith et al. (25) may well   TABLE JA" have been derived from tissue stores. This is suggested also by the lower myocardial Mg in dogs with hemorrhagic hypotension (9).
Protection against anoxia; ischemia by magnesium
Laboratory models. There is laboratory evidence that magnesium salts protect against hypoxic damage to the heart (Tables 3A-C) . Harris et al. (26) first demonstrated that either the sulfate or chloride of magnesium, given in !ravenously at a dosage of I mEq/liter suppressed the tachycardia and ectopic rhythm that had been caused by coronary ligation in 46 and 70% of the test dogs, respectively (Table  3A) . Clark and Cummings (27) (Table 38) . Hochrein and Lossnitzer (34) tested only the aspartates in guinea pigs exposed to asphyxia and found that Mg and K aspartates, in combination, doubled the cardiac tolerance of anoxia. They found that the magnesium salt alone exerted a lesser degree of protection; the potassium salt alone was ineffective.
Studies with isolated he:lrls of rats. rabbits. and guinea pigs exposed to anoxic conditions have compared mixtures of Mg and K aspartate with Mg and K chloride (Table 3C) . The aspartates exerted a greater protective effect than the chlorides against the ECG changes and reduction in systolic amplitude caused by anoxia (31-33 . 35 . 36). In these studies. the immediate effect of anoxia was to increase the rate of perfusion of the fluid (maintained under   TABLE 3Ba constant pressure) through the coronary arteries of hearts being perfused with the balanced perfusion fluid (containing Mg and KCI). Rosen and associates (35) showed that when Mg and K aspartates were substituted for the chlorides. there were much greater rates of flow through the coronaries, whether the perfusion fluid was anoxic or normally oxygenated . Possibly this was a retlection of the greater systolic amplitude of the hearts perfused with fluids containing the aspartates (Fig. 1) .
The foregoing studies reported protection by the magnesium salts (with and without potassium) that do not seem to be predominantly a function of a substantial effect on coronary blood flow. This is not to negate the known coronary dilation produced by even relatively low concentration of MgCI 2 {37 . 3R from apoplexy in Japan was higher in soft water areas than where the water was hard. Schroeder (41 -45) then correlated the death rates from hypertensive and arteriosclerotic heart disease in the states with the average hardness of drinking water 3 and found an inverse correlation. This was particularly notable for white men of 45 lo 64 years of age as regards coronary heart disease death rates. The scatter graph ( Fig. 2) shows that . with few exceptions, the states with the hardest drinking water had lower, and the states with the softest water had higher than average, death rates from ischemic heart disease. Further analysis of the states with the hardest and softest water reveals the markedly greater susceptibility to fatal heart attacks of white men aged 45 to 64 , as compared with the total (age adjusted) male population ( Fig. 3) .
It is possible that this substantial difference may be caused by a racial difference in susceptibility to this disease. This is suggested by the figures from such southern states as Coronary llow increased over perfused nonanoxic heart Coron01ry flow increased in both nonanoxic and anoxic hearts Alabama and South Carolina where the white male versus total male coronary death rates are 433 : 176 and 619 :217/100,000, respectively, and where the nonwhite population contributing to the total figures is predominantly black. Phillips and Burch ( 46) analyzed the literature in which the racial incidence of ischemic heart disease was given and evaluated their own data; they also found a significantly greater incidence of ischemic heart disease among white than black men . Bersohn (47) and Bersohn and Oelofse (48) also commented on the much greater susceptibility to ischemic heart disease of the African whites than the blacks and considered the higher serum Mg of the blacks a possibly significant factor. Figure 3 also demonstrates that the more highly industrialized and more densely popu· lated states tend to have higher coronary death ~Average hardness figures hide m01jor differences in hardness of water in different areas, particularly in la~J!e states.
~~Les than do the rural states. Comparison uf d.e-.lth rates in three cities with hard. average. QDd soft water. illustrates strikingly the intlu--oce of the "water protective factor'' in the high risk group (Fig. 4 ) . There has since been corroboration that the \,'<tcidence of ischemi<.: heart disease is higher in c:;vft than in hard water areas (49 -61 ). C:~lcium <ilrtd magnesium have been considered as pos-.._\bly protective factors, with both contributing -tlO the hardness of the water. As calcium is u.s,ually present in larger amounts than is suggest that the protective effect of hard water is due to the magnesium component. In terms of percentage variation in death rates. he found that magnesium was more effective than total hardness, which in turn was more effective th:Jn calcium in favorably inlluencing the rate of sudden deaths from ischemi..: heart disease ( 
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SEELIG AND HEGGTVEIT magnesium content of the water was 4 : 16, respectively . He and his t.:o-workers (6R) later conduded, on the basis of their own extensive analyses as well as from indirect evidence (69 ), that a good argument could be made for the existence of magnesium defkiency in the United States. They accepted as likely that diets high in calories and low in magnesium are atherogenic . They questioned. however. whether the amount of magnesium provided by hard water is sufficient to serve as the only protective factor against deaths from cardiovascular dise ase . Goldsm ith (70) and Hankin and Goldsmith and Margen (71) have calculated that 12% of the daily Mg intake is derived from water. Among those using hard water only. as much as 18% of the Mg intake was from water (70) . an amount that may well be critical. The question as to what it is in hard water that affords protection against both the development of coronary arteriosclerosis and lhe sudden death following an infarction is still controversial. The only definitive experimental study of the effect of calcium and magnesium in drinking water (on development of atherosclerosis) is that reported by Neal and Neal (7:!). They found that rabbits on atherogenic diets that were given hard water to drink had less arterial damage than did those given distilled water. Addition to the distilled water of magnesium but not calcium completely protected against arteriosclerosis. 4 The findings of Crawfo rd and Crawford (54) that men under 40, who were living in a soft water area and who had died in accidents, had lower coronary magnesium levels and greater evidence of prior myocardial disease than did comparable men from a hard water area (Fig. 7) support the contention that lower magnesium levels are related to dinical ischemic heart disease. The higher coronary magnesi um levels in the older age groups were postulated by the authors to have been caused by deposition of mineral deposits (Mg as well as Ca) in established coronary lesions. That life-long exposure to soft water is not necessary for higher death rates to be manifest is indil.:ated by the evidence that softening previously hard water resulted in significantly elevated death rates from cardiovascular diseases from those in the community before the hard drinking water had been softened (52. 58. 59). 25. 20o-209) . They have shown that estrogen or:JI ~ontracept ives lower serum magnesium levels both in women {206, 207. 209 ) and in rats ( 25 . 206 . ~OH ).
The antagonism of magnesium for calcium for dotting f:~~· rors (210). even al concentrations produced :~fter om I :Jdministration ( 182). has bc:en cunstc.lc:red :~nother explanalion of irs (Fig. •>) and Jogs (Fig. I 0) •c;age o f magnesi um required fo r favorable t'ects in the above study (2 I 3 ). That this >se rvation has dinil::. d relevance is suggested the tendency of peo ple in the Occident to nsume too much fat and by the evidence that amin 0 2 intake , too. may be excessive in :ne of those wh o drink fo rtified milk (2~4-6 ). whereas the Occidental diet tends to be v in magnesium (68 . b9 ). Thi s combination dietary imbalances may produce sufficient 1 gnesium deficiency to con tribute to the rdiovasc.:ular disease problems of the Wes tern >rid (I. 2, 69. 227 . 228). terns . The evidence as to its impo rtance in maintaining mitocho ndrial integrity and in reta ining m yo~.::.~rdi a l po t:J ssium has been considered elsewhere ( I). Magnesium is involved in normal mitochondrial contraction with fo rmation of the ~.:ompad Mg-ATP complex and is involved in the electron transpo rt system (Fig.  I 1) . With depletion of cardiac magnesium . whether from i s~.:hemia o r cardiotoxk drugs . mitocho ndri:JI swelling progresses to disorganization and disruption ( Fig. I 2) . T he importan~.:e of magnesium and potassium in myocardial aerobic metabolism has been stressed by Laborit (1 68). who studied the effects of the aspartates of these cations in experimental cardiac an oxia (supra vide). and by Nieper and Blum berger ( 172) who introduced the use of the substances in the clinic. The latter investigators consider the intr:~cellu lar metabolic effects of magnesium far more important in the treatment of c. :ardiat: is~:hemia than its antithrombotic.: effects. They have pointed out that Parsons et al. (I nO) , who stressed the importance of the at:tivation of fibrinolysis by magnesium, c.:ommen ted on the striking improvement in mortality rates of patients with infarctions on MgS04 as ~:om pared with the one·third fatality rate when routine anticoagulant therapy was used (the year before institution of the magnesium therapeutic regimen). Nieper and Blumberger (172) recommend use of the magnesium and potassium aspartates on the grounds that better penetration by Mg and K o f the cell membrane may thereby be provided . They have reported that such treatment has t:orrected the abnormal oxidative metabolism of the ischemic.: or digitalis-treated heart , as measured by an increase to a more normal pyruvic acid/lactic acid ratio and by elevation of a-ketoglutamic add (an indicator of activation of the tricarboxylit: acid cycle) . Simon ( 175) considers all of the dted mechanisms to be operative in the favorable effects of Mg in the treatment of myocardial infarction, a judgment in which the present authors concur.
Concluding comments
The usefulness of magnesium in ischemic heart disease is probably best explained by its metabolic effects at the cellular level, but its interrelations with lipid metabolism and coagulation-11brinolytic mechanisms are probably also significant. It I) c. :ounteracts the adverse effet:ls of exc. :essive intracellular caldum . 2) plays an important role in retaining intracellular potassium . and 3) is important in maintainin the integrity of the sub cellular structures. It role in maintaining normal rhythmicity of th heart in the face of an ischemic insult may wei explain the difference in sudden cardiac deat l rates in hard and soft water areas. Therapeut i. use of magnesium in acute ischemic hea r disease may well be justit1ed. The long-tern prophylac.:tic use of magnesium for the inhibt tion of atherogenesis or the prevention of acut< ischemic attac.:k, or both, requires further stud y 4 
